Craft

Alentis Therapeutics

Total Funding

$95.3 M

Alentis Therapeutics Summary

Company Summary

Overview
Alentis Therapeutics is a company that discovers and develops medications to treat liver diseases such as liver fibrosis, cirrhosis, and cancer. The company develops platform technologies and monoclonal antibodies. Its platform allows for the efficient discovery of compounds and targets that are relevant in the pathology of late-stage liver diseases.
Type
Private
Status
Active
Founded
1993
HQ
Basel, CH | view all locations
Website
https://alentis.ch/
Cybersecurity rating
Sectors

Table of Contents

LocationsView all

1 location detected

  • Basel, BS HQ

    Switzerland

    Hochbergerstrasse 60

Footer menu